Categories: HealthcareNews

TerrAscend to Host First Quarter 2025 Earnings Conference Call

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

TORONTO, April 03, 2025 (GLOBE NEWSWIRE) — TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that it will host a scheduled conference call to discuss the results for its first quarter ended March 31, 2025 on Thursday, May 8, 2025 at 5:00 p.m. Eastern Time. The Company will report its financial results for the first quarter 2025 the same day after market close.

CONFERENCE CALL DETAILS
   
Date: Thursday, May 8, 2025
Time: 5:00 p.m. Eastern Time
Webcast: https://app.webinar.net/1alJj3eQxYP
Dial-in Number: 1-888-510-2154
Replay: 1-289-819-1450 or 1-888-660-6345

Available until 12:00 midnight Eastern Time on Thursday, May 22, 2025
Replay Entry Code: 76466#

   

About TerrAscend
TerrAscend is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including vertically integrated operations in Pennsylvania, New Jersey, Maryland, Michigan and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend operates The Apothecarium, Gage and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. For more information visit www.terrascend.com.

For more information regarding TerrAscend:
Keith Stauffer
Chief Financial Officer
ir@terrascend.com
717-343-5386
IR@terrascend.com

Briana Chester
MATTIO Communications
424-465-4419
terrascend@mattio.com

Investor Relations Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
Valter@KCSA.com 
212-896-1254

Staff

Recent Posts

Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy

1,000 GMP doses of MDMA now reaching patients with PTSD under Australia's Authorised Prescriber Scheme;…

43 minutes ago

Contour Design Signs Agreement to Acquire Active Key Business from Cherry SE

COPENHAGEN, Denmark, May 8, 2025 /PRNewswire/ -- Contour Design, a global leader in ergonomic computer input…

2 hours ago

Nordic Bioscience announces PRO-C3 launched by Roche Diagnostics on cobas analysers

HERLEV, Denmark , May 8, 2025 /PRNewswire/ -- Nordic Bioscience announces that its PRO-C3 test is…

2 hours ago

QDX Congratulates Co-Founder and Head of Research A/Prof. Giuseppe Barca on Receiving the 2025 Dirac Medal

SINGAPORE, May 8, 2025 /PRNewswire/ -- QDX proudly congratulates its Co-Founder and Head of Research,…

2 hours ago

ATrack Solutions Named Business Affiliate of The Council of Autism Service Providers (CASP)

ST. AUGUSTINE, Fla., May 7, 2025 /PRNewswire/ -- ATrack Solutions, a leading provider of ABA-focused clinical…

8 hours ago